LNSR missed EPS expectations by 96.08%
Aug 16, 2025, 10:35 AM
0.00%
What does LNSR do
LENSAR, based in Orlando, Florida, develops femtosecond laser technology for cataract surgery and went public on September 21, 2020. Its product line includes the LENSAR Laser System and ALLY System, enhancing surgical outcomes.
LENSAR (LNSR) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, LENSAR's actual EPS was -$0.15, missing the estimate of -$0.08 per share, resulting in a -96.08% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.